These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32420596)

  • 21. c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.
    Tao J; Zhao X; Tao J
    Cell Cycle; 2014; 13(2):191-8. PubMed ID: 24394940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma.
    Mutzbauer G; Maurus K; Buszello C; Pischimarov J; Roth S; Rosenwald A; Chott A; Geissinger E
    Mod Pathol; 2018 Mar; 31(3):505-516. PubMed ID: 29052597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways.
    Jin HY; Oda H; Lai M; Skalsky RL; Bethel K; Shepherd J; Kang SG; Liu WH; Sabouri-Ghomi M; Cullen BR; Rajewsky K; Xiao C
    EMBO J; 2013 Aug; 32(17):2377-91. PubMed ID: 23921550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges.
    Scarmozzino F; Pizzi M; Pelizzaro F; Angerilli V; Dei Tos AP; Piazza F; Savarino EV; Zingone F; Fassan M
    Front Oncol; 2023; 13():1273305. PubMed ID: 38023263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repressing the repressor: a new mode of MYC action in lymphomagenesis.
    Sander S; Bullinger L; Wirth T
    Cell Cycle; 2009 Feb; 8(4):556-9. PubMed ID: 19197161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells.
    Abe W; Nasu K; Nakada C; Kawano Y; Moriyama M; Narahara H
    Hum Reprod; 2013 Mar; 28(3):750-61. PubMed ID: 23293219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.
    Mihailovich M; Bremang M; Spadotto V; Musiani D; Vitale E; Varano G; Zambelli F; Mancuso FM; Cairns DA; Pavesi G; Casola S; Bonaldi T
    Nat Commun; 2015 Nov; 6():8725. PubMed ID: 26555894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
    Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
    Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
    Cheminant M; Bruneau J; Malamut G; Sibon D; Guegan N; van Gils T; Cording S; Trinquand A; Verkarre V; Lhermitte L; Brousse N; Jannot AS; Khater S; Frenzel L; Delarue R; Suarez F; Marçais A; Mulder CJ; Macintyre E; Asnafi V; Pouyet L; Bonnafous C; Lhospice F; Molina TJ; Meresse B; Cellier C; Cerf-Bensussan N; Hermine O;
    Gut; 2019 Aug; 68(8):1396-1405. PubMed ID: 30448772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.
    Lollies A; Hartmann S; Schneider M; Bracht T; Weiß AL; Arnolds J; Klein-Hitpass L; Sitek B; Hansmann ML; Küppers R; Weniger MA
    Leukemia; 2018 Jan; 32(1):92-101. PubMed ID: 28659618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell repertoires in refractory coeliac disease.
    Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
    Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted Next-generation Sequencing Reveals a Wide Morphologic and Immunophenotypic Spectrum of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma.
    Hang JF; Yuan CT; Chang KC; Wang RC; Chen BJ; Hsieh PP; Huang WT; Chuang WY; Chen TW; Yeh YC; Lin SY; Hsiao CH; Chou SC; Tseng CE; Pan ST; Chang SL; Chuang SS
    Am J Surg Pathol; 2022 Sep; 46(9):1207-1218. PubMed ID: 35551151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Truth lies below: A case report and literature review of typical appearing polyps yet with an atypical diagnosis.
    Fisher A; Yousif E; Piper M
    World J Gastrointest Endosc; 2019 Jan; 11(1):54-60. PubMed ID: 30705732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenetic landscape of lymphomagenesis in coeliac disease.
    Cording S; Lhermitte L; Malamut G; Berrabah S; Trinquand A; Guegan N; Villarese P; Kaltenbach S; Meresse B; Khater S; Dussiot M; Bras M; Cheminant M; Tesson B; Bole-Feysot C; Bruneau J; Molina TJ; Sibon D; Macintyre E; Hermine O; Cellier C; Asnafi V; Cerf-Bensussan N;
    Gut; 2022 Mar; 71(3):497-508. PubMed ID: 33579790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple cerebral lesions in a patient with refractory celiac disease: A case report.
    Horvath L; Oberhuber G; Chott A; Effenberger M; Tilg H; Gunsilius E; Wolf D; Iglseder S
    World J Gastroenterol; 2020 Dec; 26(47):7584-7592. PubMed ID: 33384556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.